January 21, 2026

Lipocine completes Phase III enrolment for LPCN 1154 in PPD

​Lipocine has completed the enrolment and participant dosing in its Phase III clinical trial investigating LPCN 1154 to treat PPD.The...

January 21, 2026

Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies

​Novo Nordisk and Aspect Biosystems have started a new phase in their ongoing partnership focused on curative cellular medicines to...

January 20, 2026

Passwordless authentication at top of healthcare IT leaders’ priorities, report shows

​A new survey by security firm Imprivata has found that a majority of IT leaders in healthcare view ‘passwordless’ authentication...

January 20, 2026

Hospital cybersecurity: the threat in every HCP’s pocket

​The use of mobile devices in hospitals to streamline workflows and improve patient care has become commonplace. For cyber-attackers, this...

January 20, 2026

Guardant and MSD collaborate on companion diagnostics development

​Guardant Health has entered a multi-year strategic partnership agreement with Merck (MSD) for the development of companion diagnostics.The post Guardant...

January 20, 2026

Nxera reports positive outcomes for daridorexant Phase III insomnia study

​Nxera Pharma has announced positive top-line results from its Phase III study of daridorexant 50 mg, aimed at treating insomnia...

January 20, 2026

iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson’s

​iRegene Therapeutics has received RMAT designation from the US FDA for its lead product, NouvNeu001, aimed at treating PD.The post...

January 19, 2026

Zylox-Tonbridge to acquire German medical technology company Optimed

​Zylox-Tonbridge, a Hong Kong-listed company, has agreed to acquire German medical technology company Optimed.The post Zylox-Tonbridge to acquire German medical...

January 19, 2026

Genmab reports top line results in Phase III DLBCL trial

​Genmab has announced topline results from the Phase III EPCORE DLBCL-1 trial, highlighting improved PFS for its subcutaneous bispecific antibody,...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.